Should You Hold West Pharmaceutical Services (WST)?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. After a strong start to 2025, U.S.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Durable Capital Partners Henry Ellenbogen | 1,573,119 | $352,189,882 | +147% | 3.15% |
| 2. | Bill & Melinda Gates Foundation Trust Michael Larson | 444,500 | $99,514,660 | 0.24% | |
| 3. | Millennium Management Israel Englander | 304,403 | $68,149,744 | +39% | 0.04% |
| 4. | Citadel Investment Group Ken Griffin | 280,727 | $62,849,161 | -59% | 0.01% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 243,900 | $54,604,332 | +3541% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | $5,677.40 | 66,251 | 2019-02-28 | Filing | |
| $110.55 | 57 | $6,301.52 | 66,197 | 2018-07-31 | Filing | |
| $93.94 | 335 | $31,468.79 | 66,475 | 2017-10-17 | Filing | |
| $88.89 | 275 | $24,444.31 | 56,540 | 2018-05-15 | Filing | |
| $84.53 | 332 | $28,063.30 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | $69,840.00 | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | $148,371.20 | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | $150,000.00 | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | $158,700.00 | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | $225,772.64 | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,231,721 | $2,066,797,697 | 0.04% | |
| 2. | 6,930,119 | $1,551,515,090 | 0.03% | |
| 3. | 3,375,321 | $755,666,790 | 0.15% | |
| 4. | 3,268,478 | $731,746,933 | 1.05% | |
| 5. | 3,203,536 | $717,207,640 | 0.03% |
News See All
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Swiss Transparent Portfolio’s Substack. In this article, we will summarize the bulls’ thesis on WST.
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory
We came across a bullish thesis on West Pharmaceutical Services, Inc. (WST) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on WST.
West Pharmaceutical Services (WST) Fell on Disappointing Guidance
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why West Pharmaceutical Services (WST) Stock Fell 38%
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs...
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript April 24, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
15 Low Profile Dividend Champions to Buy
Companies known as Dividend Aristocrats belong to the S&P Index and have raised their dividend payments every year for a minimum of 25 years.
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript February 13, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
Billionaire Hedge Funds
